RAFAEL MARÍA
CANTÓN MORENO
Profesor asociado
Hospital General Universitario de Valencia
Valencia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital General Universitario de Valencia (15)
2023
-
Antimicrobial resistance in Gram-negative bacilli in Spain: an experts’ view
Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 65-81
2022
-
Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)
Microbiology spectrum, Vol. 10, Núm. 5, pp. e0292722
-
In Vitro Activity of Cefepime-Taniborbactam against Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa Isolates Recovered in Spain
Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 3
-
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3163-3172
2021
-
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 2, pp. 370-379
-
Simulating the impact of non-pharmaceutical interventions limiting transmission in COVID-19 epidemics using a membrane computing model
MicroLife, Vol. 2
2020
-
WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain
JAC-Antimicrobial Resistance, Vol. 2, Núm. 4
2019
-
Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: The SUPERIOR multicentre study
International Journal of Antimicrobial Agents, Vol. 53, Núm. 5, pp. 682-688
2018
-
Susceptibility testing and detection of β-lactam resistance mechanisms in Enterobacteriaceae: a multicentre national proficiency study
International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 612-619
2017
-
Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436
2016
-
Estudios de coste-efectividad con MALDI-TOF e impacto clínico
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, pp. 47-52
2014
-
Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: A multicenter external proficiency study using a well-defined collection of escherichia coli strains
Journal of Clinical Microbiology, Vol. 52, Núm. 1, pp. 122-129
2010
-
Actividad comparativa de doripenem, meropenem e imipenem en aislados recientes obtenidos durante el estudio de vigilancia epidemiológica COMPACT-España
Revista Espanola de Quimioterapia, Vol. 23, Núm. 3, pp. 144-152
2008
-
Diagnosis and treatment of bronchiectasis
Archivos de Bronconeumologia, Vol. 44, Núm. 11, pp. 629-640
2003
-
Evolución de la resistencia antibiótica de Pseudomonas aeruginosa, Escherichia coli y Bacteroides fragilis (1997-2001)
Revista Espanola de Quimioterapia, Vol. 16, Núm. 4, pp. 421-427